Skip to main content
Premium Trial:

Request an Annual Quote

Stimulus Money to Support Recent Un-funded Proposals

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to review and fund some grant applications from the past year that did not receive awards for 2008 and 2009 under the American Recovery and Reinvestment Act of 2009.

The aim of this NIH program is to select existing peer-reviewed, meritorious grant applications that can be accomplished in two years or less, meet the goals of the ARRA, and meet the priorities of NIH centers.

Under the program, existing applications eligible for consideration of two-year funding include those from fiscal years 2008 and 2009 that received meritorious priority scores from the initial peer review process, that received approval from an Advisory Council or Board prior to September 30, 2009, and that received priority scores that could not otherwise be paid in fiscal years 2008 and 2009.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.